geographic atrophy
3 Presenters Skew Chronic Disease Management Facts
About 30% of podium presentations on novel geographic atrophy therapies exaggerate efficacy or hide adverse events, skewing chronic disease management facts for clinicians. These distortions arise from selective data reporting, financial conflicts and over-optimistic language at major ophthalmology meetings. Understanding the bias is essential before changing practice. Medical Disclaimer: This